Business Television – Algernon Pharmaceuticals and the DMT/Stroke Clinical Program
Join Christopher J. Moreau, CEO of Algernon …
Streetwise Live! – Algernon is Awaiting Approval for a Phase 1 DMT Human Stroke Study
Listen to Cyndi Edwards, host of Streetwise Live!, speak with …
Proactive Investors Interview – Algernon Pharmaceuticals Discloses Novel Salt Patent Strategy for DMT Intellectual Property
Algernon Pharmaceuticals CEO Christopher Moreau joined Steve …